Loading…
Reported covered position: Director of Member Services, Senator John Cornyn; Whip Liaison, Senator Jon Kyl; Internal Communications Advisor, Senator Lamar Alexander
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: AIRBUS AMERICAS, INC. · Firm: TIBER CREEK GROUP
Issues related to border security; Issues related to H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to Fiscal Year 2027 appropriations for the Department of Homeland Security.
U.S. Innovation and Global Competitiveness Act of 2026
Client: SWISS RE AMERICAN HOLDING CORPORATION · Firm: TIBER CREEK GROUP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SECURE IDENTITY, LLC (DBA CLEAR) via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to H.R. 9152 - Veterans Electronic Trust and Records Authentication (VETRA) Act.
Issues related to H.R. 4213 - Department of Homeland Security Appropriations Act, 2026 (issues related to staffing reimbursement for the TSA); Issues related to modernization of TSA and travel security.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Transportation, Dept of (DOT), Veterans Affairs, Dept of (VA)
Source: Senate LDA
| 2018–2025 |
| ASSOCIATION FOR CLINICAL ONCOLOGY | 28 | 2020–2026 |
| DEUTSCHE BANK USA (FKA DEUTSCHE BANK SECURITIES INC.) | 28 | 2018–2024 |
| TIBER CREEK HEALTH STRATEGIES, INC. ON BEHALF OF ELI LILLY AND COMPANY | 28 | 2020–2026 |
| ORGANON, LLC | 23 | 2021–2026 |
| NATIONAL IMMIGRATION FORUM ACTION (FKA AMERICA IS BETTER) | 21 | 2021–2026 |
| THE BUSINESS ROUNDTABLE | 21 | 2020–2025 |
| FINSECA | 20 | 2021–2026 |
| MISSISSIPPI COUNTY, ARKANSAS | 20 | 2022–2026 |
| BOYD GAMING CORPORATION | 19 | 2019–2024 |
| STRIDE | 19 | 2020–2024 |
| GRID UNITED LLC | 18 | 2022–2026 |
| MODIVCARE SOLUTIONS, LLC | 18 | 2020–2024 |
| SMITHS GROUP PLC | 17 | 2019–2022 |
| THE CAPITAL GROUP COMPANIES, INC. AND ITS AFFILIATES | 17 | 2018–2022 |
| INFUSYSTEMS HOLDINGS, INC. | 16 | 2019–2022 |
| NUSANO, INC. | 14 | 2023–2026 |
| PREVENT OPIOID ABUSE | 14 | 2020–2023 |
| JAZZ PHARMACEUTICALS | 12 | 2019–2022 |
| SECURE IDENTITY, LLC (DBA CLEAR) | 12 | 2024–2026 |
| EFA EDUCATION, LLC | 11 | 2021–2023 |
| ELECTION SYSTEMS & SOFTWARE, LLC | 11 | 2018–2021 |
| PHLOW CORPORATION | 10 | 2024–2026 |
| VERTEX PHARMACEUTICALS | 10 | 2024–2026 |
| UBER TECHNOLOGIES INC. | 9 | 2018–2020 |
| MASTERCARD | 8 | 2023–2026 |
| TIBER CREEK HEALTH STRATEGIES, INC. (OBO COMPREHENSIVE HEALTH MANAGEMENT, INC.) | 8 | 2018–2019 |
| AIRBUS AMERICAS, INC. | 7 | 2025–2026 |
| CAPG | 7 | 2018–2019 |
| HEALTHEQUITY | 7 | 2019–2020 |
| INCYTE CORPORATION | 7 | 2025–2026 |
| INTERNATIONAL SOCIETY OF OPTICS AND PHOTONICS | 7 | 2025–2026 |
| LABWARE, INC. | 7 | 2020–2021 |
| MANAGED FUNDS ASSOCIATION | 7 | 2021–2022 |
| KOLMAR AMERICAS, INC. | 6 | 2018–2019 |
| QUALCOMM INC | 6 | 2021–2022 |
| RISE8 | 6 | 2025–2026 |
| ARCXIS | 5 | 2025–2026 |
| American Society of Clinical Oncology, Inc. | 5 | 2019 |
| IRIS AUTOMATION INC. | 5 | 2020–2021 |
| THE ALLSTATE CORPORATION | 5 | 2018 |
| ACCENTURE | 4 | 2018 |
| BAY BRIDGE STRATEGIES (ON BEHALF OF KINSA, INC.) | 4 | 2020–2021 |
| FEEDING AMERICA | 4 | 2020–2021 |
| HUMANITY FORWARD | 4 | 2022 |
| JEPPESEN FOREFLIGHT | 4 | 2026 |
| MICHIGAN POTASH COMPANY, LLC | 4 | 2018 |
| PHRMA | 4 | 2018 |
| WORLDWIDE ELECTRIC CORPORATION | 4 | 2025–2026 |
| ATLAS CROSSING (ON BEHALF OF VIRGIN HYPERLOOP ONE) | 3 | 2019 |
| BRISTOL MYERS SQUIBB | 3 | 2021 |
| CA TECHNOLOGIES, INC. | 3 | 2018 |
| DH DIAGNOSTICS, LLC | 3 | 2026 |
| QUIDNET ENERGY INC. | 3 | 2024–2025 |
| AEVA TECHNOLOGIES, INC. | 2 | 2026 |
| BIOSCRIP | 2 | 2018–2019 |
| SWISS RE AMERICAN HOLDING CORPORATION | 2 | 2026 |
| AVENUE SOLUTIONS | 1 | 2020 |
| AVFUEL CORPORATION | 1 | 2020 |
| COGNYTE SOFTWARE LP | 1 | 2026 |
| DEFINIUM THERAPEUTICS | 1 | 2026 |
| SIRVA | 1 | 2020 |
Issues related to appropriate tax treatment of reinsurance firms/transactions; Issues related to H.R. 10431 - U.S. Innovation and Global Competitiveness Act of 2026.
Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act.
Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act.
Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
New Era of Preventing End-Stage Kidney Disease Act
Client: VERTEX PHARMACEUTICALS · Firm: TIBER CREEK GROUP
Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act.
New Era of Preventing End-Stage Kidney Disease Act
Client: VERTEX PHARMACEUTICALS · Firm: TIBER CREEK GROUP
Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act.
New Era of Preventing End-Stage Kidney Disease Act
Client: VERTEX PHARMACEUTICALS · Firm: TIBER CREEK GROUP
Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act.
Issues related to H.R. 1566 - REPAIR Act; Issues related to H.R. 8800 - Small Business Cybersecurity Assistance Evaluation Act of 2026; Issues related to S. 4784 - National Defense Authorization Act for Fiscal Year 2027.
Issues related to right to repair; Issues related to H.R. 1566 - REPAIR Act.
Issues related to H.R. 1566 - REPAIR Act; Issues related to H.R. 8800 - Small Business Cybersecurity Assistance Evaluation Act of 2026; S. 4784 - National Defense Authorization Act for Fiscal Year 2027.
Maintaining Investments in New Innovation Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
Maintaining Investments in New Innovation Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
Maintaining Investments in New Innovation Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
Keep STEM Talent Act of 2025
Client: INTERNATIONAL SOCIETY OF OPTICS AND PHOTONICS · Firm: TIBER CREEK GROUP
Issues related to H.R. 2627/S. 1233 - Keep STEM Talent Act of 2025; Issues related to H.R. 4393 - DIGNIDAD (Dignity) Act of 2025.
Keep STEM Talent Act of 2025
Client: INTERNATIONAL SOCIETY OF OPTICS AND PHOTONICS · Firm: TIBER CREEK GROUP
Issues related to H.R. 2627/S. 1233 - Keep STEM Talent Act of 2025; Issues related to H.R. 4393 - DIGNIDAD (Dignity) Act of 2025.
Keep STEM Talent Act of 2025
Client: INTERNATIONAL SOCIETY OF OPTICS AND PHOTONICS · Firm: TIBER CREEK GROUP
Issues related to H.R. 2627/S. 1233 - Keep STEM Talent Act of 2025; Issues related to H.R. 4393 - DIGNIDAD (Dignity) Act of 2025.
Improving Seniors’ Timely Access to Care Act of 2025
Client: ASSOCIATION FOR CLINICAL ONCOLOGY · Firm: TIBER CREEK GROUP
Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to drug shortages; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to NIH/NCI funding; Issues related to H.R. 3514/S. 1816 - Improving Seniors Timely Access to Care Act of 2025.
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Resident Physician Shortage Reduction Act of 2025
Client: THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) · Firm: TIBER CREEK GROUP
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60); Issues related to H.R. 4191/S. 1784 - MAPS Act; Issues related to H.R. 3955/S. 2062 - RAPID Reserve Act.
Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60); Issues related to H.R. 4191/S. 1784 - MAPS Act; Issues related to H.R. 3955/S. 2062 - RAPID Reserve Act.
Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027; Issues related to H.R. 4191/S. 1784 - MAPS Act; Issues related to H.R. 3955/S. 2062 - RAPID Reserve Act.
Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60); Issues related to H.R. 4191/S. 1784 - MAPS Act; Issues related to H.R. 3955/S. 2062 - RAPID Reserve Act.
Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60); Issues related to H.R. 4191/S. 1784 - MAPS Act; Issues related to H.R. 3955/S. 2062 - RAPID Reserve Act.
Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027; Issues related to H.R. 4191/S. 1784 - MAPS Act; Issues related to H.R. 3955/S. 2062 - RAPID Reserve Act.
Department of Homeland Security Appropriations Act, 2026
Client: SECURE IDENTITY, LLC (DBA CLEAR) · Firm: TIBER CREEK GROUP
Issues related to H.R. 4213 - Department of Homeland Security Appropriations Act, 2026 (issues related to staffing reimbursement for the TSA); Issues related to modernization of TSA and travel security.
Department of Homeland Security Appropriations Act, 2026
Client: SECURE IDENTITY, LLC (DBA CLEAR) · Firm: TIBER CREEK GROUP
Issues related to H.R. 4213 - Department of Homeland Security Appropriations Act, 2026 (issues related to staffing reimbursement for the TSA); Issues related to modernization of TSA and travel security.
Department of Homeland Security Appropriations Act, 2026
Client: SECURE IDENTITY, LLC (DBA CLEAR) · Firm: TIBER CREEK GROUP
Issues related to H.R. 4213 - Department of Homeland Security Appropriations Act, 2026 (issues related to staffing reimbursement for the TSA); Issues related to modernization of TSA and travel security.
DIGNIDAD (Dignity) Act of 2025
Client: INTERNATIONAL SOCIETY OF OPTICS AND PHOTONICS · Firm: TIBER CREEK GROUP
Issues related to H.R. 2627/S. 1233 - Keep STEM Talent Act of 2025; Issues related to H.R. 4393 - DIGNIDAD (Dignity) Act of 2025.
DIGNIDAD (Dignity) Act of 2025
Client: INTERNATIONAL SOCIETY OF OPTICS AND PHOTONICS · Firm: TIBER CREEK GROUP
Issues related to H.R. 2627/S. 1233 - Keep STEM Talent Act of 2025; Issues related to H.R. 4393 - DIGNIDAD (Dignity) Act of 2025.
DIGNIDAD (Dignity) Act of 2025
Client: INTERNATIONAL SOCIETY OF OPTICS AND PHOTONICS · Firm: TIBER CREEK GROUP
Issues related to H.R. 2627/S. 1233 - Keep STEM Talent Act of 2025; Issues related to H.R. 4393 - DIGNIDAD (Dignity) Act of 2025.
Securing Infrastructure from Adversaries Act of 2025
Client: AEVA TECHNOLOGIES, INC. · Firm: TIBER CREEK GROUP
Issues related to self-driving technologies; H.R. 4802 - Securing Infrastructure from Adversaries Act of 2025; H.R. 6576 - SAFE LiDAR Act.
Securing Infrastructure from Adversaries Act of 2025
Client: AEVA TECHNOLOGIES, INC. · Firm: TIBER CREEK GROUP
Issues related to self-driving technologies; H.R. 4802 - Securing Infrastructure from Adversaries Act of 2025; H.R. 6576 - SAFE LiDAR Act.
Securing Infrastructure from Adversaries Act of 2025
Client: AEVA TECHNOLOGIES, INC. · Firm: TIBER CREEK GROUP
Issues related to H.R. 4802 - Securing Infrastructure from Adversaries Act of 2025; Issues related to self-driving technologies.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to aviation safety technology; Issues related to H.R. 6222/S. 2503 - ROTOR Act; Issues related to H.R. 7613 - ALERT Act.
Issues related to aviation safety technology; Issues related to H.R. 6222/S. 2503 - ROTOR Act; Issues related to H.R. 7613 - ALERT Act.
Issues related to aviation safety technology; Issues related to H.R. 6222/S. 2503 - ROTOR Act; Issues related to H.R. 7613 - ALERT Act.
Issues related to H.R. 6337/S. 2651 - ROAD to Housing Act of 2025; Issues related to H.R. 6644 - 21st Century ROAD to Housing Act; Issues related to housing affordability.
SAFE Drugs Act of 2025
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY) · Firm: TIBER CREEK GROUP
Issues related to drug pricing; Issues related to reimbursement of insulin products; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to compounding and H.R. 6509/S. 3794 - Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act of 2025.
SAFE Drugs Act of 2025
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY) · Firm: TIBER CREEK GROUP
Issues related to drug pricing; Issues related to reimbursement of insulin products; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to compounding and H.R. 6509 - Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act of 2025; Issues related to FDA guidance on Alcohol Use Disorder (AUD).
SAFE Drugs Act of 2025
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY) · Firm: TIBER CREEK GROUP
Issues related to drug pricing; Issues related to reimbursement of insulin products; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to compounding and H.R. 6509 - Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act of 2025.
Issues related to self-driving technologies; H.R. 4802 - Securing Infrastructure from Adversaries Act of 2025; H.R. 6576 - SAFE LiDAR Act.
Issues related to H.R. 6576 - SAFE LiDAR Act.
Issues related to self-driving technologies; H.R. 4802 - Securing Infrastructure from Adversaries Act of 2025; H.R. 6576 - SAFE LiDAR Act.
Issues related to H.R. 6337/S. 2651 - ROAD to Housing Act of 2025; Issues related to H.R. 6644 - 21st Century ROAD to Housing Act; Issues related to housing affordability.
TRIA Program Reauthorization Act of 2026
Client: SWISS RE AMERICAN HOLDING CORPORATION · Firm: TIBER CREEK GROUP
Issues related to H.R. 7128/S. 4395 - TRIA Program Reauthorization Act of 2026.
Issues related to point of care testing and digital pathology; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to infectious disease diagnostics.
Issues related to point of care testing and digital pathology; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to point of care testing; Issues related to H.R. 7352 - PASTEUR Act of 2026.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Farm, Food, and National Security Act of 2026
Client: CASE NEW HOLLAND INDUSTRIAL INC · Firm: TIBER CREEK GROUP
Issues related to Farm Bill reauthorization; Issues related to H.R. 7567 - Farm, Food, and National Security Act of 2026, and in discussion draft, the Agricultural Act of 2026 (Farm Bill 2.0).
Farm, Food, and National Security Act of 2026
Client: CASE NEW HOLLAND INDUSTRIAL INC · Firm: TIBER CREEK GROUP
Issues related to Farm Bill reauthorization; Issues related to H.R. 7567 - Farm, Food, and National Security Act of 2026, and in discussion draft, the Agricultural Act of 2026 (Farm Bill 2.0).
Farm, Food, and National Security Act of 2026
Client: CASE NEW HOLLAND INDUSTRIAL INC · Firm: TIBER CREEK GROUP
Issues related to Farm Bill reauthorization; Issues related to H.R. 7567 - Farm, Food, and National Security Act of 2026.
Issues related to aviation safety technology; Issues related to H.R. 6222/S. 2503 - ROTOR Act; Issues related to H.R. 7613 - ALERT Act.
Issues related to aviation safety technology; Issues related to H.R. 6222/S. 2503 - ROTOR Act; Issues related to H.R. 7613 - ALERT Act.
Issues related to aviation safety technology; Issues related to H.R. 6222/S. 2503 - ROTOR Act; Issues related to H.R. 7613 - ALERT Act.
National Defense Authorization Act for Fiscal Year 2027
Client: AIRBUS AMERICAS, INC. · Firm: TIBER CREEK GROUP
Issues related to defense appropriations; Issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027.
National Defense Authorization Act for Fiscal Year 2027
Client: ORGANON, LLC · Firm: TIBER CREEK GROUP
Issues related to implementation of drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to drug pricing; Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to Servicemember Quality of Life Improvement; Issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027.
National Defense Authorization Act for Fiscal Year 2027
Client: AIRBUS AMERICAS, INC. · Firm: TIBER CREEK GROUP
Issues related to defense appropriations; Issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027.
National Defense Authorization Act for Fiscal Year 2027
Client: CASE NEW HOLLAND INDUSTRIAL INC · Firm: TIBER CREEK GROUP
Issues related to H.R. 1566 - REPAIR Act; Issues related to H.R. 8800 - Small Business Cybersecurity Assistance Evaluation Act of 2026; Issues related to S. 4784 - National Defense Authorization Act for Fiscal Year 2027.
National Defense Authorization Act for Fiscal Year 2027
Client: PHLOW CORPORATION · Firm: TIBER CREEK GROUP
Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027; Issues related to H.R. 4191/S. 1784 - MAPS Act; Issues related to H.R. 3955/S. 2062 - RAPID Reserve Act.
National Defense Authorization Act for Fiscal Year 2027
Client: CASE NEW HOLLAND INDUSTRIAL INC · Firm: TIBER CREEK GROUP
Issues related to H.R. 1566 - REPAIR Act; Issues related to H.R. 8800 - Small Business Cybersecurity Assistance Evaluation Act of 2026; S. 4784 - National Defense Authorization Act for Fiscal Year 2027.
Energy and Water Development and Related Agencies Appropriations Act, 2027
Client: NUSANO, INC. · Firm: TIBER CREEK GROUP
Issues related to funding for domestic radioisotopes, uranium, and nuclear fuel rod remediation and recycling; Issues related to H.R. 9022 - Energy and Water Development and Related Agencies Appropriations Act, 2027.
Energy and Water Development and Related Agencies Appropriations Act, 2027
Client: NUSANO, INC. · Firm: TIBER CREEK GROUP
Issues related to funding for domestic radioisotopes, uranium, and nuclear fuel rod remediation and recycling; Issues related to H.R. 9022 - Energy and Water Development and Related Agencies Appropriations Act, 2027.
Issues related to H.R. 9152 - Veterans Electronic Trust and Records Authentication (VETRA) Act.
Issues related to H.R. 9152 - Veterans Electronic Trust and Records Authentication (VETRA) Act.
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2027
Client: MISSISSIPPI COUNTY, ARKANSAS · Firm: TIBER CREEK GROUP
Issues related to securing federal appropriations in H.R. 9170 -Transportation, Housing and Urban Development, and Related Agencies Appropriations Act; Issues related to environmental clean-up of contaminated buildings within the county; Issues related to securing federal appropriations to secure new taxiway lights for the Blytheville Aeroplex; Issues related to upgrades to buildings for the Blytheville Aeroplex.
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to Medicaid Rebates; Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.
Affordable Prescriptions for Patients Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY) · Firm: TIBER CREEK GROUP
Issues related to intellectual property; Issues related to S. 1041 - Affordable Prescriptions for Patients Act; Issues related to patent thickets; Issues related to S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act.
Affordable Prescriptions for Patients Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY) · Firm: TIBER CREEK GROUP
Issues related to intellectual property; Issues related to S. 1041 - Affordable Prescriptions for Patients Act; Issues related to patent thickets; Issues related to S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act; Issues related to S.2658 - Medication Affordability and Patent Integrity Act.
Affordable Prescriptions for Patients Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY) · Firm: TIBER CREEK GROUP
Issues related to intellectual property; Issues related to S. 1041 - Affordable Prescriptions for Patients Act; Issues related to patent thickets; Issues related to S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act; Issues related to S.2658 - Medication Affordability and Patent Integrity Act.
Preserve Access to Affordable Generics and Biosimilars Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY) · Firm: TIBER CREEK GROUP
Issues related to intellectual property; Issues related to S. 1041 - Affordable Prescriptions for Patients Act; Issues related to patent thickets; Issues related to S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act; Issues related to S.2658 - Medication Affordability and Patent Integrity Act.
Preserve Access to Affordable Generics and Biosimilars Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY) · Firm: TIBER CREEK GROUP
Issues related to intellectual property; Issues related to S. 1041 - Affordable Prescriptions for Patients Act; Issues related to patent thickets; Issues related to S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act; Issues related to S.2658 - Medication Affordability and Patent Integrity Act.
Preserve Access to Affordable Generics and Biosimilars Act
Client: TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY) · Firm: TIBER CREEK GROUP
Issues related to intellectual property; Issues related to S. 1041 - Affordable Prescriptions for Patients Act; Issues related to patent thickets; Issues related to S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act.
Keep STEM Talent Act of 2025
Client: INTERNATIONAL SOCIETY OF OPTICS AND PHOTONICS · Firm: TIBER CREEK GROUP
Issues related to H.R. 2627/S. 1233 - Keep STEM Talent Act of 2025; Issues related to H.R. 4393 - DIGNIDAD (Dignity) Act of 2025.
Keep STEM Talent Act of 2025
Client: INTERNATIONAL SOCIETY OF OPTICS AND PHOTONICS · Firm: TIBER CREEK GROUP
Issues related to H.R. 2627/S. 1233 - Keep STEM Talent Act of 2025; Issues related to H.R. 4393 - DIGNIDAD (Dignity) Act of 2025.
Keep STEM Talent Act of 2025
Client: INTERNATIONAL SOCIETY OF OPTICS AND PHOTONICS · Firm: TIBER CREEK GROUP
Issues related to H.R. 2627/S. 1233 - Keep STEM Talent Act of 2025; Issues related to H.R. 4393 - DIGNIDAD (Dignity) Act of 2025.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027; Issues related to H.R. 4191/S. 1784 - MAPS Act; Issues related to H.R. 3955/S. 2062 - RAPID Reserve Act.
NUSANO, INC. via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to promoting domestic production of radioisotopes, High-Assay Low-Enriched Uranium (HALEU) and critical minerals.
Issues related to funding for domestic radioisotopes, uranium, and nuclear fuel rod remediation and recycling; Issues related to H.R. 9022 - Energy and Water Development and Related Agencies Appropriations Act, 2027.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to brokers and the Medicare program.
Issues related to insurance coverage, ACA market reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERTEX PHARMACEUTICALS via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to coverage of opioid alternatives.
Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED SERVICES AUTOMOBILE ASSOCIATION via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to insurance underwriting; Issues related to flood insurance.
Issues related to network access and competition in electronic credit transactions; Issues related to payments legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY) via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to drug pricing and reimbursement for prescription drugs; Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to S. 3267 - ASAP Act.
Issues related to intellectual property; Issues related to S. 1041 - Affordable Prescriptions for Patients Act; Issues related to patent thickets; Issues related to S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act; Issues related to S.2658 - Medication Affordability and Patent Integrity Act.
Issues related to drug pricing; Issues related to reimbursement of insulin products; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to compounding and H.R. 6509/S. 3794 - Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act of 2025.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR CLINICAL ONCOLOGY via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to drug shortages; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to NIH/NCI funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JEPPESEN FOREFLIGHT via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to defense aviation technology; Issues related to navigational data.
Issues related to appropriations and spending on aviation safety and navigational software and equipment.
Issues related to aviation safety technology; Issues related to H.R. 6222/S. 2503 - ROTOR Act; Issues related to H.R. 7613 - ALERT Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
Issues related to tariff policy and supply chain policy.
GRID UNITED LLC via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to electricity transmission and permitting reform.
Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
AIRBUS AMERICAS, INC. via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to the aerospace industry.
Issues related to border security; Issues related to Fiscal Year 2027 appropriations for the Department of Homeland Security.
Issues related to defense appropriations; Issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INCYTE CORPORATION via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to Medicaid Rebates; Issues related to Health and Human Services Center for Medicare and Medicaid Innovation GUARD Demo; Issues related to Medicare coverage of Vitilligo.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DH DIAGNOSTICS LLC via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to funding for diagnostics.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to point of care testing and digital pathology; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to infectious disease diagnostics.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WORLDWIDE ELECTRIC CORPORATION via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Q3
Issues related to Department of Defense Appropriations.
Issues related to SBIR Contracts; Issues related to S. 853 - INNOVATE Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL SOCIETY OF OPTICS AND PHOTONICS via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to H.R. 2627/S. 1233 - Keep STEM Talent Act of 2025; Issues related to H.R. 4393 - DIGNIDAD (Dignity) Act of 2025.
Issues related to reauthorization of the National Quantum Initiative.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CASE NEW HOLLAND INDUSTRIAL INC via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to free trade agreements; Issues related to United States-Mexico-Canada Agreement enforcement; Issues related to China; Issues related to sector-specific tariffs; Issues related to chips.
Issues related to Farm Bill reauthorization; Issues related to H.R. 7567 - Farm, Food, and National Security Act of 2026, and in discussion draft, the Agricultural Act of 2026 (Farm Bill 2.0).
Issues related to H.R. 1566 - REPAIR Act; Issues related to H.R. 8800 - Small Business Cybersecurity Assistance Evaluation Act of 2026; Issues related to S. 4784 - National Defense Authorization Act for Fiscal Year 2027.
NATIONAL IMMIGRATION FORUM ACTION (FKA AMERICA IS BETTER) via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to immigration and border security.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SWISS RE AMERICAN HOLDING CORPORATION via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to appropriate tax treatment of reinsurance firms/transactions; Issues related to H.R. 10431 - U.S. Innovation and Global Competitiveness Act of 2026.
Issues related to trade and tariffs.
Issues related to Third Party Litigation Funding.
PHLOW CORPORATION via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to domestic pharmaceutical production.
Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60); Issues related to H.R. 4191/S. 1784 - MAPS Act; Issues related to H.R. 3955/S. 2062 - RAPID Reserve Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORGANON, LLC via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to implementation of drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to drug pricing; Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues related to implementation of drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to drug pricing; Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 (PL 118-159).
MISSISSIPPI COUNTY, ARKANSAS via TIBER CREEK GROUP
2026 · third_quarter · Q3
Issues related to securing federal appropriations in H.R. 9170 -Transportation, Housing and Urban Development, and Related Agencies Appropriations Act; Issues related to environmental clean-up of contaminated buildings within the county; Issues related to securing federal appropriations to secure new taxiway lights for the Blytheville Aeroplex; Issues related to upgrades to buildings for the Blytheville Aeroplex.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DEFINIUM THERAPEUTICS via TIBER CREEK GROUP
2026 · third_quarter · RR
Issues related to FDA approved Psychedelics; Issues related to DEA rescheduling of FDA approved products.
Issues related to FDA approved Psychedelics; Issues related to DEA rescheduling of FDA approved products.
SWISS RE AMERICAN HOLDING CORPORATION via TIBER CREEK GROUP
2026 · third_quarter · RR
Issues related to the Terrorism Risk Insurance Program; issues related to third-party litigation funding; issues related to international trade; issues related to reinsurance taxation.
Issues related to the Terrorism Risk Insurance Program; issues related to third-party litigation funding; issues related to international trade; issues related to reinsurance taxation.
Issues related to the Terrorism Risk Insurance Program; issues related to third-party litigation funding; issues related to international trade; issues related to reinsurance taxation.
COGNYTE SOFTWARE LP via TIBER CREEK GROUP
2026 · second_quarter · RR
Issues related to election security.
NATIONAL IMMIGRATION FORUM ACTION (FKA AMERICA IS BETTER) via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to immigration and border security.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
SECURE IDENTITY, LLC (DBA CLEAR) via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to H.R. 4213 - Department of Homeland Security Appropriations Act, 2026 (issues related to staffing reimbursement for the TSA); Issues related to modernization of TSA and travel security.
Issues related to H.R. 9152 - Veterans Electronic Trust and Records Authentication (VETRA) Act.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Transportation, Dept of (DOT), Veterans Affairs, Dept of (VA)
MASTERCARD via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to interchange, cost of acceptance, debit interchange price controls, and routing mandates for credit cards; Issues related to artificial intelligence and payment security.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DH DIAGNOSTICS LLC via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to point of care testing and digital pathology; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026.
Issues related to funding for diagnostics.
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352/S. 4875 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JEPPESEN FOREFLIGHT via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to aviation safety technology; Issues related to H.R. 6222/S. 2503 - ROTOR Act; Issues related to H.R. 7613 - ALERT Act.
Issues related to defense aviation technology; Issues related to navigational data.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED SERVICES AUTOMOBILE ASSOCIATION via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to network access and competition in electronic credit transactions; Issues related to payments legislation and issues related to bank reform legislation.
Issues related to insurance underwriting; Issues related to flood insurance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUSANO, INC. via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to promoting domestic production of radioisotopes, High-Assay Low-Enriched Uranium (HALEU) and critical minerals.
Issues related to funding for domestic radioisotopes, uranium, and nuclear fuel rod remediation and recycling; Issues related to H.R. 9022 - Energy and Water Development and Related Agencies Appropriations Act, 2027.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY) via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to intellectual property; Issues related to S. 1041 - Affordable Prescriptions for Patients Act; Issues related to patent thickets; Issues related to S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act; Issues related to S.2658 - Medication Affordability and Patent Integrity Act.
Issues related to drug pricing; Issues related to reimbursement of insulin products; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to compounding and H.R. 6509 - Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act of 2025.
NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to brokers and the Medicare program.
Issues related to insurance coverage, ACA market reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR CLINICAL ONCOLOGY via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to drug shortages; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to NIH/NCI funding; Issues related to H.R. 3514/S. 1816 - Improving Seniors Timely Access to Care Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INCYTE CORPORATION via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to Medicaid Rebates; Issues related to Health and Human Services Center for Medicare and Medicaid Innovation GUARD Demo.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIRBUS AMERICAS, INC. via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to defense appropriations; Issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027.
Issues related to the aerospace industry.
Issues related to border security; Issues related to Fiscal Year 2027 appropriations for the Department of Homeland Security.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MISSISSIPPI COUNTY, ARKANSAS via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to securing federal appropriations in the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to environmental clean-up of contaminated buildings within the county; Issues related to securing federal appropriations to update the existing sewer lines in Mississippi County; Issues related to upgrades for the Blytheville Aeroplex.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CASE NEW HOLLAND INDUSTRIAL INC via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to H.R. 1566 - REPAIR Act; Issues related to H.R. 8800 - Small Business Cybersecurity Assistance Evaluation Act of 2026; S. 4784 - National Defense Authorization Act for Fiscal Year 2027.
Issues related to free trade agreements; Issues related to United States-Mexico-Canada Agreement enforcement; Issues related to China; Issues related to sector-specific tariffs; Issues related to chips.
Issues related to Farm Bill reauthorization; Issues related to H.R. 7567 - Farm, Food, and National Security Act of 2026, and in discussion draft, the Agricultural Act of 2026 (Farm Bill 2.0).
WORLDWIDE ELECTRIC CORPORATION via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERTEX PHARMACEUTICALS via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to coverage of opioid alternatives.
Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Q2
Issues related to Department of Defense Appropriations.
Issues related to SBIR Contracts; Issues related to S. 853 - INNOVATE Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL SOCIETY OF OPTICS AND PHOTONICS via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to reauthorization of the National Quantum Initiative.
Issues related to H.R. 2627/S. 1233 - Keep STEM Talent Act of 2025; Issues related to H.R. 4393 - DIGNIDAD (Dignity) Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHLOW CORPORATION via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027; Issues related to H.R. 4191/S. 1784 - MAPS Act; Issues related to H.R. 3955/S. 2062 - RAPID Reserve Act.
Issues related to domestic pharmaceutical production.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORGANON, LLC via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to implementation of drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to drug pricing; Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues related to women's health.
Issues related to implementation of drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to drug pricing; Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to Servicemember Quality of Life Improvement; Issues related to H.R. 8800/S. 4784 - National Defense Authorization Act for Fiscal Year 2027.
TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
Issues related to tariff policy and supply chain policy.
GRID UNITED LLC via TIBER CREEK GROUP
2026 · second_quarter · Q2
Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Issues related to electricity transmission and permitting reform.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
MASTERCARD via TIBER CREEK GROUP
2026 · first_quarter · 1A
Issues related to interchange, cost of acceptance, debit interchange price controls, and routing mandates for credit cards; Issues related to artificial intelligence and payment security.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHLOW CORPORATION via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to domestic pharmaceutical production.
Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60); Issues related to H.R. 4191/S. 1784 - MAPS Act; Issues related to H.R. 3955/S. 2062 - RAPID Reserve Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORGANON, LLC via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to implementation of drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to drug pricing; Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues related to implementation of drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to drug pricing; Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 (PL 118-159)
DH DIAGNOSTICS LLC via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to reimbursement for diagnostic tests; Issues related to H.R. 5269/S. 2761 - RESULTS Act; Issues related to H.R. 7352 - PASTEUR Act of 2026; Issues related to H.R. 6197/S. 1399 - Health Tech Investment Act; Issues related to H.R. 6130/S. 3267 - ASAP Act.
Issues related to point of care testing; Issues related to H.R. 7352 - PASTEUR Act of 2026.
Issues related to funding for diagnostics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL IMMIGRATION FORUM ACTION (FKA AMERICA IS BETTER) via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to immigration and border security.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to 340B Drug Pricing Program; General intellectual property issues; Issues related to pharmacy benefit managers; Issues related to Most Favored Nation (MFN) policy.
Issues related to tariff policy and supply chain policy.
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
GRID UNITED LLC via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Issues related to electricity transmission and permitting reform.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NUSANO, INC. via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to promoting domestic production of radioisotopes, High-Assay Low-Enriched Uranium (HALEU) and critical minerals.
Issues related to funding for domestic radioisotopes, uranium, and nuclear fuel rod remediation and recycling.
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to insurance coverage, ACA market reforms, and telemedicine flexibilities; Issues related to the extension of Enhanced Advanced Premium Tax Credits (EAPTCs); Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CASE NEW HOLLAND INDUSTRIAL INC via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to Farm Bill reauthorization; Issues related to H.R. 7567 - Farm, Food, and National Security Act of 2026.
Issues related to right to repair; Issues related to H.R. 1566 - REPAIR Act.
Issues related to free trade agreements; Issues related to United States-Mexico-Canada Agreement enforcement; Issues related to China; Issues related to sector-specific tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WORLDWIDE ELECTRIC CORPORATION via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERTEX PHARMACEUTICALS via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act; Issues related to H.R. 1518 - New Era of Preventing End-Stage Kidney Disease Act.
Issues related to coverage of opioid alternatives.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Q1
Issues related to SBIR Contracts; Issues related to S. 853 - INNOVATE Act.
Filing targets: SENATE
INTERNATIONAL SOCIETY OF OPTICS AND PHOTONICS via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to reauthorization of the National Quantum Initiative.
Issues related to H.R. 2627/S. 1233 - Keep STEM Talent Act of 2025; Issues related to H.R. 4393 - DIGNIDAD (Dignity) Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JEPPESEN FOREFLIGHT via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to aviation safety technology; Issues related to H.R. 6222/S. 2503 - ROTOR Act; Issues related to H.R. 7613 - ALERT Act.
Issues related to defense aviation technology; Issues related to navigational data.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MISSISSIPPI COUNTY, ARKANSAS via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to securing federal appropriations in the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to environmental clean-up of contaminated buildings within the county; Issues related to securing federal appropriations to update the existing sewer lines in Mississippi County; Issues related to upgrades for the Blytheville Aeroplex.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIRBUS AMERICAS, INC. via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to the aerospace industry.
Issues related to defense appropriations; Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to 2027 National Defense Authorization Act.
Issues related to border security; Issues related to H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to Fiscal Year 2027 appropriations for the Department of Homeland Security.
SECURE IDENTITY, LLC (DBA CLEAR) via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to H.R. 4213 - Department of Homeland Security Appropriations Act, 2026 (issues related to staffing reimbursement for the TSA); Issues related to modernization of TSA and travel security.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Transportation, Dept of (DOT)
MASTERCARD via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to interchange, cost of acceptance, debit interchange price controls, and routing mandates for credit cards; Issues related to the GENIUS Act (PL 119-27); Issues related to artificial intelligence and payment security; Issues related to open banking.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Q1
Issues related to retirement security; Information Reporting of Certain Life Insurance Contract Transactions and Modifications to the Transfer for Valuable Consideration Rules (REG-103083-18).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED SERVICES AUTOMOBILE ASSOCIATION via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to network access and competition in electronic credit transactions; Issues related to payments legislation and issues related to bank reform legislation; Issues related to Basel III Endgame.
Issues related to insurance underwriting; Issues related to flood insurance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY) via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to drug pricing; Issues related to reimbursement of insulin products; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to compounding and H.R. 6509 - Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act of 2025; Issues related to FDA guidance on Alcohol Use Disorder (AUD).
Issues related to drug pricing and reimbursement for prescription drugs; Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the One Big Beautiful Bill Act (PL 119-21).
THE ICKES AND ENRIGHT GROUP (ON BEHALF OF GREATER NEW YORK HOSPITAL ASSOCIATION) via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues impacting the hospital industry; Issues impacting hospital reimbursement; Issues related to workforce development and graduate medical education; Issues related to H.R. 3890/S. 2439 - Resident Physician Shortage Reduction Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Q1
Issues related to H.R. 6337/S. 2651 - ROAD to Housing Act of 2025; Issues related to H.R. 6644 - 21st Century ROAD to Housing Act; Issues related to housing affordability.
Filing targets: Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE
ASSOCIATION FOR CLINICAL ONCOLOGY via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Issues related to drug shortages; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to NIH/NCI funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AEVA TECHNOLOGIES, INC. via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to H.R. 6576 - SAFE LiDAR Act.
Issues related to H.R. 4802 - Securing Infrastructure from Adversaries Act of 2025; Issues related to self-driving technologies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INCYTE CORPORATION via TIBER CREEK GROUP
2026 · first_quarter · Q1
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to Medicaid Rebates; Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JEPPESEN FOREFLIGHT via TIBER CREEK GROUP
2026 · first_quarter · RR
Issues related to aviation safety and aviation software technology.
Issues related to aviation safety and aviation software technology.
AEVA TECHNOLOGIES, INC. via TIBER CREEK GROUP
2026 · first_quarter · RR
Issues related to self-driving technologies; H.R. 4802 - Securing Infrastructure from Adversaries Act of 2025; H.R. 6576 - SAFE LiDAR Act.
Issues related to self-driving technologies; H.R. 4802 - Securing Infrastructure from Adversaries Act of 2025; H.R. 6576 - SAFE LiDAR Act.
INCYTE CORPORATION via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to Medicare Part D and Part B Pricing Reform; Issues related to Medicaid Rebates; Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF NOVARTIS) via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to tariff policy and supply chain policy.
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to drug pricing; Issues related to One Big Beautiful Bill Act (PL 119-21); Issues related to H.R. 1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; Issues related to H.R. 1672 - Maintaining Investments in New Innovation Act.
GRID UNITED LLC via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issue related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169).
Issues related to electricity transmission and permitting reform.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
CASE NEW HOLLAND INDUSTRIAL INC via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to free trade agreements; Issues related to United States-Mexico-Canada Agreement enforcement; Issues related to China; Issues related to sector-specific tariffs.
Issues related to Farm Bill reauthorization.
Issues related to right to repair; Issues related to H.R. 1566 - REPAIR Act; Issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUSANO, INC. via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to promoting domestic production of radioisotopes, High-Assay Low-Enriched Uranium (HALEU) and critical minerals.
Issues related to funding for domestic radioisotopes, uranium, and nuclear fuel rod remediation and recycling.
Filing targets: Defense, Dept of (DOD), Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE, White House Office
NATIONAL ASSOCIATION OF BENEFITS AND INSURANCE PROFESSIONALS (FKA NAHU) via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to insurance coverage, ACA market reforms, and telemedicine flexibilities; Issues related to H.R. 247/S. 46 - Health Care Affordability Act of 2025; Issues related to the extension of Enhanced Advanced Premium Tax Credits (EAPTCs).
Issues related to broker compensation in Medicare Advantage.
Issues related to health savings accounts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL IMMIGRATION FORUM ACTION (FKA AMERICA IS BETTER) via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to immigration and border security.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AIRBUS AMERICAS, INC. via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to the aerospace industry.
Issues related to defense appropriations; Issues related to H.R. 4016/S. 2572 - Department of Defense Appropriations Act, 2026; Issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60).
Issues related to border security; Issues related to H.Con.Res.14 - Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034; Issues related to the One Big Beautiful Bill Act (PL 119-21).
SECURE IDENTITY, LLC (DBA CLEAR) via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to H.R. 4213 - Department of Homeland Security Appropriations Act, 2026 (issues related to staffing reimbursement for the TSA); Issues related to modernization of TSA and travel security.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASTERCARD via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to interchange, cost of acceptance, debit interchange price controls, and routing mandates for credit cards; Issues related to the GENIUS Act (PL 119-27); Issues related to artificial intelligence and payment security; Issues related to open banking.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Q4
Issues related to retirement security; Information Reporting of Certain Life Insurance Contract Transactions and Modifications to the Transfer for Valuable Consideration Rules (REG-103083-18).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Q4
Issues related to S. 2651 - ROAD to Housing Act of 2025; Issues related to housing affordability.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHLOW CORPORATION via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to domestic pharmaceutical production.
Issues related to H.R. 5304/S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; Issues related to H.R. 4016/S. 2572 - Department of Defense Appropriations Act, 2026; Issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60); Issues related to H.R. 4191/S. 1784 - MAPS Act; Issues related to H.R. 3955/S. 2062 - RAPID Reserve Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MISSISSIPPI COUNTY, ARKANSAS via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to securing federal appropriations in H.R. 4552/S. 2645 - Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2026; Issues related to environmental clean-up of contaminated buildings within the county; Issues related to securing federal appropriations to update the existing sewer lines in Mississippi County; Issues related to upgrades for the Blytheville Aeroplex.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ORGANON, LLC via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to implementation of drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to drug pricing; Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 (PL 118-159)
Issues related to implementation of drug pricing and reimbursement for prescription drugs related to Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to drug pricing; Issues related to the implementation of the American Relief Act of 2025 (PL 118-158); Issues related to the One Big Beautiful Bill Act (PL 119-21).
VERTEX PHARMACEUTICALS via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to drug pricing; Issues related to H.R. 1227/S. 475 - Alternatives to PAIN Act.
Issues related to opioid alternatives; Issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60).
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
WORLDWIDE ELECTRIC CORPORATION via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTERNATIONAL SOCIETY OF OPTICS AND PHOTONICS via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to reauthorization of the National Quantum Initiative.
Issues related to H.R. 2627/S. 1233 - Keep STEM Talent Act of 2025.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Q4
Issues related to SBIR Contracts; Issues related to H.R. 4777/S. 853 - INNOVATE Act.
Filing targets: SENATE
UNITED SERVICES AUTOMOBILE ASSOCIATION via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to network access and competition in electronic credit transactions; Issues related to payments legislation and issues related to bank reform legislation; Issues related to Basel III Endgame.
Issues related to insurance underwriting; Issues related to flood insurance.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TPI COMPOSITES, INC. via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues pertaining to the wind industry, tax, and trade.
Issues pertaining to the wind industry, tax, and trade; Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues pertaining to the wind industry, tax, and trade.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY) via TIBER CREEK GROUP
2025 · fourth_quarter · Q4
Issues related to drug pricing and reimbursement for prescription drugs; Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the One Big Beautiful Bill Act (PL 119-21).
Issues related to drug pricing; Issues related to reimbursement of insulin products; Issues related to H.R. 4231/S. 1973 - Treat and Reduce Obesity Act of 2025; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to compounding and H.R. 6509 - Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act of 2025.
Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to 340B Drug Pricing Program; General intellectual property issues; Issues related to pharmacy benefit managers; Issues related to Most Favored Nation (MFN) policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to H.R. 7128/S. 4395 - TRIA Program Reauthorization Act of 2026.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Issues related to women's health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the Terrorism Risk Insurance Program; issues related to third-party litigation funding; issues related to international trade; issues related to reinsurance taxation.
Issues related to drug pricing and reimbursement for prescription drugs; Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the One Big Beautiful Bill Act (PL 119-21).
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to drug pricing; Issues related to the One Big Beautiful Bill Act (PL 119-21); Issues related to 340B Drug Pricing Program; General intellectual property issues; Issues related to pharmacy benefit managers; Issues related to Most Favored Nation (MFN) policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to women's health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to intellectual property; Issues related to S. 1041 - Affordable Prescriptions for Patients Act; Issues related to patent thickets; Issues related to S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Issues related to drug pricing; Issues related to One Big Beautiful Bill Act (PL 119-21); Issues related to 340B Drug Pricing Program; General intellectual property issues; Issues related to pharmacy benefit managers; Issues related to Most Favored Nation (MFN) policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to women's health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to intellectual property; Issues related to S. 1041 - Affordable Prescriptions for Patients Act; Issues related to patent thickets; Issues related to S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE